Related Experiment Video
Updated: Jul 2, 2025
08:51
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
9.0K
COVID-19 Vaccination Coverage and Associated Factors in Patients with Multiple Sclerosis
Ignacio Hernández-García1,2, Joana Rodríguez-Montolio3, Monserrath Almeida-Zurita3
1Department of Preventive Medicine and Public Health, Lozano Blesa University Clinical Hospital of Zaragoza, Calle San Juan Bosco 15, 50009 Zaragoza, Spain.
Vaccines
|February 24, 2024
Summary
COVID-19 vaccination coverage in multiple sclerosis (MS) patients reached 90.3% for initial doses, higher than in other countries. However, booster dose uptake decreased, necessitating targeted strategies, especially for women under 60.
Area of Science:
- Neurology
- Immunology
- Public Health
Background:
- Multiple sclerosis (MS) is a chronic neurological disease.
- COVID-19 vaccination is crucial for vulnerable populations, including MS patients.
- Understanding vaccination coverage and associated factors in MS patients is vital for public health strategies.
Purpose of the Study:
- To determine COVID-19 vaccination coverage in multiple sclerosis (MS) patients.
- To identify factors associated with primary and booster COVID-19 vaccination in MS patients.
- To inform strategies for improving vaccination rates in this cohort.
Main Methods:
- Retrospective cohort study of 359 MS patients from 2017-2021.
- Data collected from specialized and primary care records.
- Bivariate analysis and multiple logistic regression models used to analyze vaccination data.
Main Results:
- 90.3% of MS patients received full primo-vaccination against COVID-19.
- Factors associated with primo-vaccination included birth in Spain and prior influenza vaccination.
- Booster dose coverage was 39.3%, associated with male sex, age 60+, progressive MS types, and recent influenza vaccination.
Conclusions:
- COVID-19 primo-vaccination coverage in MS patients is high, exceeding international levels.
- A significant drop in booster dose uptake was observed.
- Strategies beyond co-administration with influenza vaccines are needed to enhance booster coverage, particularly for younger women.
Related Concept Videos
01:18Factors Affecting Illness
4.2K
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
For instance, risk factors are connected to illness,...
4.2K
01:26Factors Affecting the Risk of Infection
11.8K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.8K
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
59
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
59
01:51Vaccinations
44.5K
Overview
44.5K
01:25Factors Influencing Drug Absorption: Disease States and Pharmacology
515
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
515
01:21Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K